Literature DB >> 19013211

Structure-activity relationships of human AKR-type oxidoreductases involved in bile acid synthesis: AKR1D1 and AKR1C4.

Wen Hwa Lee1, Petra Lukacik, Kunde Guo, Emilie Ugochukwu, Kathryn L Kavanagh, Brian Marsden, Udo Oppermann.   

Abstract

Two members of the human aldo-keto reductase (AKR) superfamily participate in the biosynthesis of bile acids by catalyzing the NADP(H) dependent reduction of 3-keto groups (AKR1C4) and Delta4 double bonds (AKR1D1) of oxysterol precursors. Structure determination of human AKR1C4 and homology modelling of AKR1D1 followed by docking experiments were used to explore active site geometries. Substrate docking resulted in ligand poses satisfying catalytic constraints, and indicates a critical role for Trp227/230 in positioning the substrate in a catalytically competent orientation. Based on the evidence gathered from our docking experiments and experimental structures, this tryptophan residue emerges as a major determinant governing substrate specificity of a subset of enzymes belonging to the AKR1 subfamily.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19013211     DOI: 10.1016/j.mce.2008.09.042

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  7 in total

1.  Systematic genetic and genomic analysis of cytochrome P450 enzyme activities in human liver.

Authors:  Xia Yang; Bin Zhang; Cliona Molony; Eugene Chudin; Ke Hao; Jun Zhu; Andrea Gaedigk; Christine Suver; Hua Zhong; J Steven Leeder; F Peter Guengerich; Stephen C Strom; Erin Schuetz; Thomas H Rushmore; Roger G Ulrich; J Greg Slatter; Eric E Schadt; Andrew Kasarskis; Pek Yee Lum
Journal:  Genome Res       Date:  2010-06-10       Impact factor: 9.043

2.  The effect of disease associated point mutations on 5β-reductase (AKR1D1) enzyme function.

Authors:  Rebekka Mindnich; Jason E Drury; Trevor M Penning
Journal:  Chem Biol Interact       Date:  2010-12-24       Impact factor: 5.192

3.  Predictors of Variation in CYP2A6 mRNA, Protein, and Enzyme Activity in a Human Liver Bank: Influence of Genetic and Nongenetic Factors.

Authors:  Julie-Anne Tanner; Bhagwat Prasad; Katrina G Claw; Patricia Stapleton; Amarjit Chaudhry; Erin G Schuetz; Kenneth E Thummel; Rachel F Tyndale
Journal:  J Pharmacol Exp Ther       Date:  2016-11-04       Impact factor: 4.030

4.  Genetic variation in aldo-keto reductase 1D1 (AKR1D1) affects the expression and activity of multiple cytochrome P450s.

Authors:  Amarjit S Chaudhry; Ranjit K Thirumaran; Kazuto Yasuda; Xia Yang; Yiping Fan; Stephen C Strom; Erin G Schuetz
Journal:  Drug Metab Dispos       Date:  2013-05-23       Impact factor: 3.922

5.  Macro-to-micro structural proteomics: native source proteins for high-throughput crystallization.

Authors:  Monica Totir; Nathaniel Echols; Max Nanao; Christine L Gee; Alisa Moskaleva; Scott Gradia; Anthony T Iavarone; James M Berger; Andrew P May; Chloe Zubieta; Tom Alber
Journal:  PLoS One       Date:  2012-02-29       Impact factor: 3.240

Review 6.  Variation in CYP2A6 Activity and Personalized Medicine.

Authors:  Julie-Anne Tanner; Rachel F Tyndale
Journal:  J Pers Med       Date:  2017-12-01

7.  Proteomics approach to investigate dynamic protein profile involved in high fat diet-induced fatty liver disease in rats.

Authors:  Baohua Huang; Yanling Yao; Yaping Li; Hua Yang; Huchen Liu; Heng Liu; Dongming Li; Wei Shu; Ming Chen
Journal:  J Toxicol Pathol       Date:  2019-03-19       Impact factor: 1.628

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.